These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 97874)

  • 1. [The patent ductus arteriosus from a perinatological viewpoint].
    Menzel K; Schambach K; Töpke B
    Z Arztl Fortbild (Jena); 1978 May; 72(10):472-7. PubMed ID: 97874
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
    Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
    J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pharmacological therapy in children--a review. Part 4: Manipulation of vascular resistance and patent ductus arteriosus.
    Chan KY; Yip WC; Tay JS
    J Singapore Paediatr Soc; 1989; 31(1-2):26-31. PubMed ID: 2671493
    [No Abstract]   [Full Text] [Related]  

  • 4. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacologic closure of the patent ductus arteriosus.
    Van Overmeire B; Chemtob S
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):177-84. PubMed ID: 15701582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment leads to closure of patent ductus arteriosus.
    Danilevicius Z
    JAMA; 1977 May; 237(21):2326. PubMed ID: 576928
    [No Abstract]   [Full Text] [Related]  

  • 7. Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications.
    Halliday HL; Hirata T; Brady JP
    Pediatrics; 1979 Aug; 64(2):154-9. PubMed ID: 471605
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonsurgical closure of patent ductus arteriosus in preterm infants.
    Smith ME
    Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708
    [No Abstract]   [Full Text] [Related]  

  • 9. [Patent ductus arteriosus in premature infants].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1455-8. PubMed ID: 19690594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
    Pai VB; Sakadjian A; Puthoff TD
    Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent ductus arteriosus in the preterm infant.
    Kirsten D
    Neonatal Netw; 1996 Mar; 15(2):19-26. PubMed ID: 8700090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandins, thromboxanes, and inhibitors of their synthesis on renal and gastrointestinal function in the newborn period.
    Friedman WF; Fitzpatrick KM
    Semin Perinatol; 1980 Apr; 4(2):143-56. PubMed ID: 6990505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of the ductus arteriosus.
    Dipalma JR
    Am Fam Physician; 1978 Jan; 17(1):194-5. PubMed ID: 414606
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters.
    Tschuppert S; Doell C; Arlettaz-Mieth R; Baenziger O; Rousson V; Balmer C; Prêtre R; Dodge-Khatami A
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):78-82. PubMed ID: 18179922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Sekar KC; Corff KE
    J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus.
    Friedman WF; Printz MP; Kirkpatrick SE
    Adv Prostaglandin Thromboxane Res; 1978; 4():373-81. PubMed ID: 565580
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment to prevent patency of the ductus arteriosus: beneficial or harmful?
    Bose CL; Laughon M
    J Pediatr; 2006 Jun; 148(6):713-4. PubMed ID: 16769371
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates.
    Giardini A; Derrick G
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):240; author reply 240. PubMed ID: 18603105
    [No Abstract]   [Full Text] [Related]  

  • 20. Ductus-dependent fetal cardiac defects contraindicate indomethacin tocolysis.
    Saenger JS; Mayer DC; D'Angelo LJ; Manci EA
    J Perinatol; 1992 Mar; 12(1):41-7. PubMed ID: 1560290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.